Does Vit C-Chromium-Chi-Bri-Herb188 Tablet Interact with other Medications?
Severe Interactions
These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- SYMPATHOMIMETICS (INDIRECT & MIXED ACTING)/MAOIS
- CYP1A2 INHIBITORS/FEZOLINETANT
- WEAK CYP3A4 INHIBITORS/LEMBOREXANT (> 5 MG)
- WEAK CYP3A4 INHIBITORS/LOMITAPIDE (>30 MG)
Serious Interactions
These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- ASPARTAME; PHENYLALANINE; TYROSINE/NITISINONE
- MIXED;INDIRECT SYMPATHOMIMETICS/SELECTED MAOIS
- MIXED;INDIRECT SYMPATHOMIMETICS/RASAGILINE
- P-GLYCOPROTEIN (P-GP) INHIBITORS/VINCRISTINE
- STRONG CYP3A4 OR MODERATE CYP2C9 INHIBITORS/ERDAFITINIB
- CYP3A4 INDUCERS/ZURANOLONE
- P-GLYCOPROTEIN (P-GP) INHIBITORS/PRALSETINIB
- CYP3A4 INDUCERS/ERLOTINIB
- GINKGO BILOBA/UBROGEPANT
- P-GLYCOPROTEIN (P-GP) INHIBITORS/BILASTINE
- SELECTED MODERATE AND WEAK CYP1A2 INHIBITORS/TIZANIDINE
- CYP3A4 INDUCERS/ATOGEPANT
- P-GLYCOPROTEIN (P-GP) INHIBITORS/DOXORUBICIN
- P-GLYCOPROTEIN (P-GP) INHIBITORS/RELUGOLIX
- WEAK CYP3A4 INHIBITORS/LONAFARNIB
- CYP3A4 INDUCERS/LUMATEPERONE
- P-GLYCOPROTEIN (P-GP) INHIBITORS/ORAL LEFAMULIN
- SELECTED MODERATE CYP2C9 INHIBITORS/SIPONIMOD
- WEAK CYP3A4 INHIBITORS/ELIGLUSTAT
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/VENETOCLAX
- SELECTED INHIBITORS OF P-GP OR BCRP/PAZOPANIB
- ASCORBIC ACID (VITAMIN C)/BORTEZOMIB
- WEAK CYP3A4 INHIBITORS/LOMITAPIDE (<=30MG)
- P-GLYCOPROTEIN (P-GP) INHIBITORS/TOPOTECAN
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/DABIGATRAN
Moderate Interactions
These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- BULK FORMING LAXATIVES/CLOZAPINE
- MODERATE AND WEAK CYP3A4 INDUCERS/TACROLIMUS
- SLT MODERATE AND WEAK CYP3A4 INHIBIT/SIROLIMUS PROTEIN-BOUND
- MODERATE AND WEAK CYP3A4 INDUCERS/UBROGEPANT
- WEAK CYP3A4 INHIBITORS/LEMBOREXANT (<= 5 MG)
- MODERATE AND WEAK CYP3A4 INHIBITORS/TACROLIMUS
- MILK THISTLE/WARFARIN
- SELECT P-GP INHIBITORS/EDOXABAN (<= 30 MG)
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/BETRIXABAN
- SELECT P-GP INHIBITORS/EDOXABAN (> 30 MG)
- SELECTED CYP1A2 INHIBITORS/THEOPHYLLINE DERIVATIVES
- SELECTED MODERATE-WEAK CYP3A4 INDUCERS/EXEMESTANE
- P-GLYCOPROTEIN (P-GP) INHIBITORS/AFATINIB
- ASCORBIC ACID (VITAMIN C)/DEFEROXAMINE
- GINKGO BILOBA/MIDAZOLAM
- GINKGO BILOBA/TOLBUTAMIDE
- CYP3A4; CYP2C8; P-GLYCOPROTEIN (P-GP) INHIBITORS/LOPERAMIDE
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.